Lpl Financial LLC Athenex, Inc. Transaction History

Lpl Financial LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$1.36 - $2.94 $32,766 - $70,833	-24,093 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$3.71 - $5.13 $1,855 - $2,565	500 Added 2.12%	24,093 $111,000
Q1 2021 May 14, 2021	BUY	$4.08 - $14.75 $16,103 - $58,218	3,947 Added 20.09%	23,593 $101,000
Q3 2020 Nov 09, 2020	BUY	$10.26 - $14.55 $51,300 - $72,750	5,000 Added 34.14%	19,646 $238,000
Q2 2020 Aug 13, 2020	BUY	$7.11 - $13.76 $104,133 - $201,528	14,646 New	14,646 $202,000
Q3 2018 Nov 14, 2018	SELL	$15.53 - $19.97 $241,274 - $310,253	-15,536 Closed	0 $0
Q2 2018 Aug 14, 2018	SELL	$15.88 - $19.5 $47,640 - $58,500	-3,000 Reduced 16.18%	15,536 $290,000
Q1 2018 May 15, 2018	BUY	$13.53 - $17.47 $250,792 - $323,823	18,536 New	18,536 $315,000

1.46M

Ticker ATNX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 156,790,000
Market Cap $1.57M
Description
Athenex, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of drugs for the treatment of cancer. It operates through three segments: Oncology Innovation Platform, Global Supply Chain Platform, and Commercial Platform. The company's Orascovery product candidates include Oral paclitaxel and encequidar,...

Get notified when there are updates to the investment portfolio of Lpl Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Lpl Financial LLC with notifications on news.